Will AbbVie Outsmart Biosimilars, And Can Clovis Oncology Win The PARP Race?
AbbVie, Inc. (NYSE:ABBV), Regeneron Pharmaceuticals (NASDAQ:REGN), and Clovis Oncology (NASDAQ:CLVS) all have at least one thing in common: All three are subjects of this week's Industry Focus: Healthcare!
In this edition, host Kristine Harjes is joined by contributor Todd Campbell. Among other topics, the two discuss:
In this edition, host Kristine Harjes is joined by contributor Todd Campbell. Among other topics, the two discuss: